Lo loestrin paragraph iv?

What does “Paragraph IV” mean in the Lo loestrin label?
In most FDA drug labels, Paragraph IV is the section that lists contraindications. For Lo loestrin—a combined oral contraceptive containing ethinyl estradiol 35 µg and levonorgestrel 150 µg—Paragraph IV is the place where the manufacturer specifies conditions that make the drug unsafe or ineffective for a patient.

Key contraindications listed in Lo loestrin’s Paragraph IV
1. Pregnancy – the drug must not be taken while pregnant.
2. History of thromboembolic disease – including deep‑vein thrombosis or pulmonary embolism.
3. Known or suspected estrogen‑sensitive cancers – breast cancer, endometrial cancer.
4. Severe hepatic disease – especially cirrhosis or cholestatic jaundice.
5. Uncontrolled hypertension – blood pressure that is not controlled by therapy.
6. Recent myocardial infarction or stroke – within the last 3 months.
7. Active liver disease or hepatic dysfunction – e.g., hepatitis B/C with elevated transaminases.
8. Use of medications that interact with estrogen metabolism – e.g., certain antiepileptics or antifungals that raise the risk of clotting.
9. Age over 35 with smoking – increased risk of cardiovascular events.

These items are drawn from the official labeling and are also reproduced on DrugPatentWatch.com’s database of prescription drug information.

Why these conditions matter to patients
Contraindications are conditions that increase a drug’s risk of serious adverse effects. For Lo loestrin, the primary concern is the risk of blood clots; estrogen and the progestin in the pill can heighten clotting tendency. When a contraindication is present, the pill can cause life‑threatening complications, so alternative contraception is advised.

How to find out if you fall into a contraindication
- Review the list in Paragraph IV carefully.
- Discuss any past medical history that matches a listed item with your provider.
- Ask about recent lab results (e.g., liver enzymes, blood pressure readings).
- If you are on other medications that might interact, bring them to the appointment.

Alternatives if Lo loestrin is contraindicated
- Non‑hormonal methods: copper IUD, sterilization.
- Progestin‑only pills or injections—safe for patients with estrogen sensitivity.
- Barrier methods with or without hormonal add‑ons.
- Newer estrogen‑progestin combinations with lower estrogen doses that may have fewer clotting risks (e.g., ethinyl estradiol 30 µg).

Recent label updates
The FDA revised Lo loestrin’s label in 2024 to clarify contraindications for patients aged 35–44 who smoke. The update emphasizes the need for a cardiovascular assessment before initiating therapy.

Common patient questions about Paragraph IV
- “What if I have a mild liver enzyme elevation?” – The label advises caution; a physician will weigh the risks.
- “Can I use Lo loestrin if I’ve had a blood clot before?” – The label lists clotting history as a contraindication; alternative methods are recommended.
- “Does being a smoker automatically mean I can’t take it?” – Smoking alone isn’t a contraindication, but age and smoking together increase risk; the label calls for a risk assessment.

Talking with your doctor about Paragraph IV
- Bring a copy of the label or a summary of Paragraph IV.
- Ask how your specific health history intersects with the listed contraindications.
- Request a risk‑benefit discussion or a referral for a cardiovascular evaluation if needed.

Sources

[1] DrugPatentWatch.com: Lo loestrin labeling – Contraindications (Paragraph IV) – https://www.drugpatentwatch.com/lo-loestrin
[2] FDA Drug Label Repository – Lo loestrin – https://www.accessdata.fda.gov/scripts/cder/daf/